Skip to main content

Diagnostic Delay of Venous Thromboembolism (DOVE) in Primary Care

CBE ID
3749e
Endorsed
New or Maintenance
New
Is Under Review
No
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Spring 2023 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Spring 2023 “Intent to Submit.” Battelle took over the E&M work for the Spring 2023 cycle when developers and/or stewards submitted their full measure information, which for CBE #3749e, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2023-06/3749e_-_diagnostic_delay_of_venous_thromboembolism_dove_in_primary_care.zip

To close out this E&M cycle, Battelle published the Spring 2023 measures for pre-evaluation public commenting, convened the E&M standing committees for their measure evaluation meetings, launched the Spring 2023 post-comment period, convened the E&M committees for the post-comment meeting, convened the CSAC to render a final endorsement decision, and executed the appeals period.

 

Measure Description

This eCQM assesses the rate of delayed diagnosis of VTE in adults aged 18 years and older in the primary care setting. Delayed diagnosis is defined as diagnosis of VTE that occurs >24 hours following the index primary care visit where symptoms for the VTE were first present (within 30 days).

  • Measure Type
    Outcome
    Level Of Analysis
    Clinician: Group/Practice
    MAT output not attached
    Attached
    Numerator

    The subset of the denominator where the patient’s VTE diagnosis occurs greater than 24 hours following a primary care visit (within 30 days).

    Denominator

    All adult patients (age 18 years and older) presenting in primary care with VTE-related symptoms, who are subsequently diagnosed with VTE following a primary care visit (within 30 days).

    Exclusions

    This eCQM excludes patients who received hospice or palliative care within 90 days of the eligible VTE event.

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
    Testing Data Sources
    Electronic Health Records
  • Risk Adjustment
    No risk adjustment or risk stratification
    Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Patient Safety Spring 2023
    Initial Endorsement
    Next Planned Maintenance Review
    Spring 2028
    Endorsement Status
    Endorsed
  • Do you have a secondary measure developer point of contact?
    Off
    The measure developer is NOT the same as measure steward
    Off
    Steward
    Brigham and Women's Hospital
  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off
    If no, attest that all information will be provided in other fields in the submission.
    Off